Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if KLRS is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
16 top institutions tracked
Last 13F trend: unchanged (light)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 1
56 filers reported a long position in KLRS for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Samsara BioCapital, LLC | $52.4M | 12.9M | -0.5% |
| RTW INVESTMENTS, LP | $5.3M | 1.3M | Unchanged |
| Alyeska Investment Group, L.P. | $2.3M | 572.7K | Unchanged |
| Siren, L.L.C. | $1.8M | 435.8K | Unchanged |
| VANGUARD CAPITAL MANAGEMENT LLC | $1.6M | 398.7K | +56.1% |
| Ikarian Capital, LLC | $1.5M | 360K | Unchanged |
| UBS Group AG | $1.1M | 262.1K | +4,138.9% |
| RENAISSANCE TECHNOLOGIES LLC | $607.9K | 149.4K | +125.8% |
| MARSHALL WACE, LLP | $566.5K | 139.2K | +105.1% |
| GEODE CAPITAL MANAGEMENT, LLC | $464.3K | 114K | +30.3% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.